Company intelligence / Profile preview

Agri-Neo

Toronto, Ontario, Canadaagri-neo.com ↗

Ownership: Private
Development stage: Other

Overview

Agri-Neo’s patented Neo-Pure technology provides a validated kill step that eliminates up to 99.999% of harmful pathogens such as Salmonella, E. coli, and Listeria from foods like nuts and seeds while maintaining their natural quality. The company has also launched Neo‑Temper for flour safety. Their solutions are adopted by leading industry partners to meet or exceed the highest standards in food safety. No clinical trials as this relates to industrial/food applications.

Therapeutic areas: Infectious Diseases
Modalities: DeviceOrganic solution-based intervention
Industry: Agriculture & AgTech

Partnerships

Sesajal (sesame seed processing partner)

Beyond the preview

Go deeper on Agri-Neo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agri-Neo.

Explore the full profile